TKIs in thyroid cancer typically target receptors such vascular endothelial growth factor receptors (VEGFR), epidermal growth factor receptors (EGFR), and other kinases involved in angiogenesis and tumor development (100). This evidence concerns the gene KDR and thyroid cancer.